I just wish I could get it all into this year's business......I'll have to wait til January now, for insurance reasons, but the main thing is....It's time to squash the bug...
Its legit. This is from the FDA website.
October 25, 2013: Antiviral Drugs Advisory Commitee Meeting Announcement
Agenda
The committee will discuss new drug application (NDA) 204671, sofosbuvir (an NS5B polymerase inhibitor), manufactured by Gilead Sciences, Inc., with a proposed indication for the treatment of chronic hepatitis C infection, in combination with other agents in adult patients with genotypes 1 to 6 and/or adult patients awaiting liver transplantation.
http://www.fda.gov/AdvisoryCommittees/Calendar/ucm368560.htm